Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)

NCT04535869 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04535869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04535869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
Lead sponsor
Mansoura University
Phase
Phase 3
Overall status
Unknown status
Start date
December 28, 2020
Completion date
September 3, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19